A very common virus can be screened easily by women with the help of their tampon.
Despite 99.8% of cervical cancers being caused by persistent high-risk human papillomavirus (HPV) infections, nearly a third of AFAB individuals aged 25-49 skipped their cervical smear in 2023, according to Metro UK.
The first-of-its-kind HPV-testing tampon has been released by gynae healthcare brand Daye in an effort to tackle this. To collect a sample of cells the tampon can be inserted by users at home.
Moreover, it can then be sent — in specific packaging — to the lab for testing, and results will be out within five to 10 days.
For STIs, including chlamydia, gonorrhoea, trichomonas, mycoplasma and ureaplasma; the company has already released a diagnostic tampon. It tests users from the comfort and convenience of their own home. Additionally, it will set them back £89.
Daye's CEO and founder Valentina Milanova, while speaking of the initiative said: "Eliminating cervical cancer by 2040 requires a joined-up approach of vaccination, screening and testing, and we hope to encourage more women and AFAB individuals to proactively test for HPV."
"By utilising the familiar tampon, this hassle-free HPV testing kit is extremely easy and comfortable to use," she added.
Disclaimer: This may not work for everyone. Consult your doctor before trying this out.
Health experts warn that HIV is far from from being stamped out and more needs to be done
Experts say that single largest reason behind egg scarcity is bird flu
Warnings include depictions of feet with amputated toes, along with written descriptions of health risks
"I'm so grateful to doctors, nurses here for giving me hope," says 57-year-old patient Cheryl Mehrkar
POB calls for intensified routine immunisation to ensure consistent access to vulnerable children
Latest cases reported from KP's Tehsil Darazinda in District Dera Ismail Khan
